摘要
目的:探讨杜密克联合微生物制剂治疗便秘型肠易激综合征(IBS)的疗效。方法:将IBS患者随机按1∶1分组,所有病例均嘱其改善不良生活习惯,治疗组采用杜密克15ml,口服,每日1次,共4周,思联康2粒,口服,每日3次,共4周;对照组采用谷维素30mg,口服,每日3次,共4周,思联康2粒,口服,每日3次,共4周。结果:治疗组总有效率为83.3%,对照组总有效率为61.7%。结论:杜密克联合微生物制剂治疗便秘型肠易激综合征效果较好。
Objectiye：To explore the effect of Duphalac secret combination microbial agents for the treatment of constipation-predominant irritable bowel syndrome（IBS）.Methods：IBS patients were randomized 1∶1 to groups,all patients were improved the poor living habits,the treatment group received Duphalac secret 15 ml oral 1 time daily for 4 weeks,the Probiotic Preparation 2 grains oral 3 times daily for 4 weeks;the control group received Oryzanol 30 mg roal 3 tims a day for 4 weeks,the Probiotic Preparation 2 grains oral 3 times daily for 4 weeks.Results：The total efficiency rate of treatment group was 83.3%,the total efficiency rate of control group was 61.7%.Conclusion：Duphalac secret combination microbial agents for the treatment of constipation-predominant irritable bowel syndrome has better effect.
出处
《中国医药导报》
CAS
2010年第24期60-60,62,共2页
China Medical Herald
关键词
杜密克
微生物制剂
肠易激综合征
Duphalac secret
Probiotic Preparation
Irritable bowel syndrome
